Evidence map›Paper›PMID 25487341›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2015

Screening ancient tuberculosis with qPCR: challenges and opportunities.

Kelly M Harkins, Jane E Buikstra, Tessa Campbell, Kirsten I Bos, Eric D Johnson, Johannes Krause, Anne C Stone

Abstract readHistorical Article
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Introduction. Ancient DNA: the first three decades.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kelly M HarkinsSchool of Human Evolution and Social Change, Arizona State University, Tempe, AZ, USA.ORCID http://orcid.org/0000-0002-0756-4250
Jane E BuikstraSchool of Human Evolution and Social Change, Arizona State University, Tempe, AZ, USA.
Tessa CampbellDepartment of Archaeology, University of Cape Town, Cape Town, South Africa.
Kirsten I BosInstitute for Archaeological Sciences, University of Tübingen, Tübingen, Germany.
Eric D JohnsonSchool of Life Sciences, Arizona State University, Tempe, AZ, USA.
Johannes KrauseInstitute for Archaeological Sciences, University of Tübingen, Tübingen, Germany.
Anne C StoneSchool of Human Evolution and Social Change, Arizona State University, Tempe, AZ, USA acstone@asu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of ancient DNA (aDNA) has rapidly accelerated in recent years as a result of new methods in next-generation sequencing, library preparation and targeted enrichment. Such research is restricted, however, by the highly variable DNA preservation within different tissues, especially when isolating ancient pathogens from human remains. Identifying positive candidate samples via quantitative PCR (qPCR) for downstream procedures can reduce reagent costs, increase capture efficiency and maximize the number of sequencing reads of the target. This study uses four qPCR assays designed to target regions within the Mycobacterium tuberculosis complex (MTBC) to examine 133 human skeletal samples from a wide geographical and temporal range, identified by the presence of skeletal lesions typical of chronic disseminated tuberculosis. Given the inherent challenges working with ancient mycobacteria, strict criteria must be used and primer/probe design continually re-evaluated as new data from bacteria become available. Seven samples tested positive for multiple MTBC loci, supporting them as strong candidates for downstream analyses. Using strict and conservative criteria, qPCR remains a fast and effective screening tool when compared with screening by more expensive sequencing and enrichment technologies.

Indexed as

FossilsBone and BonesDNA, BacterialDNA PrimersHistory, AncientHumansMycobacterium tuberculosisPaleopathologyReal-Time Polymerase Chain ReactionDNA, BacterialDNA Primersancient DNAbioarchaeologyqPCRtuberculosis

Identifiers

PMID25487341
PMCPMC4275897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.